Liposomal Vincristine as a Bridge Therapy Prior to CAR-T Therapy in Relapsed and Refractory Diffuse Large B-Cell Lymphoma?

Chadha, Juskaran; Hussein, Shafinaz; Zhan, Yougen; Shulman, Jonah; Brody, Joshua; Ratner, Lynn; Steinberg, Amir

Chadha, Juskaran; Hussein, Shafinaz; Zhan, Yougen; Shulman, Jonah; Brody, Joshua; Ratner, Lynn; Steinberg, Amir.

Afiliación

Chadha J; Department of Hematology & Medical Oncology, Lenox Hill Hospital Northwell Health, New York, NY, USA.
Hussein S; Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA.
Zhan Y; Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA.
Shulman J; Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA.
Brody J; Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA.
Ratner L; Department of Hematology & Medical Oncology, Lenox Hill Hospital Northwell Health, New York, NY, USA.
Steinberg A; Tisch Cancer Institute, Mount Sinai Hospital, New York, NY, USA.

Int J Hematol Oncol Stem Cell Res ; 13(2): 102-107, 2019 Apr 01.

Article en En | MEDLINE | ID: mdl-31372204

Palabras clave

Autologous SCT; CAR-T; DLBCL; Heavily pretreated; Liposomal vincristine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Int J Hematol Oncol Stem Cell Res Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google